CISNE Score: Prognostic model for seemingly stable solid tumor patients with febrile neutropenia. Identifies patients safe for outpatient management.
CISNE Score
Risk Assessment
1.1% Complication Risk
Verified
Last Review: 2026-07-17
| Criterion | Points |
|---|---|
| ECOG Performance Status ≥ 2 | 2 |
| Stress-induced hyperglycemia | 2 |
| COPD | 1 |
| Chronic cardiovascular disease | 1 |
| Mucositis (Grade ≥ 2) | 1 |
| Monocytes < 200/µL | 1 |
| Score | Risk Group | Risk of Complications |
|---|---|---|
| 0 | Low Risk | 1.1% |
| 1 - 2 | Intermediate Risk | 6.2% |
| ≥ 3 | High Risk | 36% |
Carmona-Bayonas A et al. • Journal of Clinical Oncology. 2015;33(5):465-71
Last Comprehensive Review: 2026-07-17
Clinical Context
We think this has broad domain relevance to CISNE Score for Febrile Neutropenia.
Clinical Context
We think this has broad domain relevance to CISNE Score for Febrile Neutropenia.
Clinical Context
We think this has broad domain relevance to CISNE Score for Febrile Neutropenia.
